INR 20.96
(-4.86%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1591.00 INR | 20.62% |
2022 | 1319.00 INR | -16.36% |
2021 | 1577.00 INR | 5.53% |
2020 | 1494.39 INR | 0.4% |
2019 | 1488.43 INR | 17.86% |
2018 | 1262.92 INR | -14.61% |
2017 | 1478.93 INR | -38.82% |
2016 | 2417.32 INR | -6.36% |
2015 | 2581.56 INR | -53.7% |
2014 | 5576.23 INR | -87.28% |
2013 | 43.83 Thousand INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q4 | 1591.10 INR | 0.0% |
2023 FY | 1591.10 INR | 20.63% |
2023 Q1 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 1319.00 INR | 0.0% |
2022 Q2 | 2981.00 INR | 0.0% |
2021 Q2 | 1928.00 INR | 0.0% |
2021 Q4 | 1577.00 INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q1 | - INR | -100.0% |
2020 Q1 | - INR | -100.0% |
2020 Q4 | 1494.39 INR | 0.0% |
2020 Q2 | 1598.00 INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2019 Q4 | 1488.43 INR | 0.0% |
2019 Q2 | 1207.00 INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2018 Q3 | - INR | -100.0% |
2018 Q4 | 1262.92 INR | 0.0% |
2018 Q2 | 2282.00 INR | 0.0% |
2018 Q1 | - INR | -100.0% |
2017 Q3 | - INR | -100.0% |
2017 Q2 | 2174.00 INR | 0.0% |
2017 Q1 | - INR | -100.0% |
2017 Q4 | 1478.93 INR | 0.0% |
2016 Q2 | 41.39 Thousand INR | 0.0% |
2016 Q3 | - INR | -100.0% |
2016 Q4 | 2417.32 INR | 0.0% |
2016 Q1 | - INR | -100.0% |
2015 Q4 | 2581.56 INR | 0.0% |
2015 Q1 | - INR | -100.0% |
2015 Q2 | 42.79 Thousand INR | 0.0% |
2015 Q3 | - INR | -100.0% |
2014 Q3 | - INR | -100.0% |
2014 Q4 | 5576.23 INR | 0.0% |
2014 Q1 | - INR | -100.0% |
2014 Q2 | 81.46 Thousand INR | 0.0% |
2013 Q2 | 85.99 Thousand INR | 0.0% |
2013 Q3 | - INR | -100.0% |
2013 Q4 | 43.83 Thousand INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Alfavision Overseas (India) Limited | 1.78 Billion INR | 100.0% |
Biocon Limited | 560.7 Billion INR | 100.0% |
Blue Jet Healthcare Limited | 10.58 Billion INR | 100.0% |
Concord Biotech Limited | 17 Billion INR | 100.0% |
Dishman Carbogen Amcis Limited | 95.81 Billion INR | 100.0% |
FERMENTA BIOTECH LIMITED | 5.47 Billion INR | 100.0% |
GENOMIC VALLEY BIOTECH LIMITED | 43.33 Million INR | 99.996% |
Lyka Labs Limited | 1.56 Billion INR | 100.0% |
Panacea Biotec Limited | 12.4 Billion INR | 100.0% |
SAMSRITA LABS LIMITED | 155.51 Million INR | 99.999% |
SMS Lifesciences India Limited | 3.9 Billion INR | 100.0% |
Supriya Lifescience Limited | 9.21 Billion INR | 100.0% |
Syngene International Limited | 61.51 Billion INR | 100.0% |
TAKE Solutions Limited | 881.05 Million INR | 100.0% |
Titan Biotech Limited | 1.56 Billion INR | 100.0% |
Transgene Biotek Limited | 324.4 Million INR | 100.0% |
Vanta Bioscience Limited | 853.96 Million INR | 100.0% |